October 26-29, 2020
Virtual Event

Connect with us at this year’s digital BIO-EUROPE and use the event’s One-on-One Partnering to e-meet with Thomas Schirrmann (CEO) and David Passmore (Business Development) and to learn more about YUMAB’s fully human antibody technology platform, its potential in drug discovery and development, and the company’s diverse business opportunities. Arrange a meeting

People attending from YUMAB:


Thomas Schirrmann, PhD
CEO & Founder

David Passmore, PhD
Business Development